Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

A Schweizer, JE Foley, W Kothny… - Vascular Health and Risk …, 2013 - Taylor & Francis
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …
被引用次数：37 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

A Schweizer - Vascular Health and Risk Management, 2013 - pdfs.semanticscholar.org
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

A Schweizer, JE Foley, W Kothny… - Vascular health and …, 2013 - pubmed.ncbi.nlm.nih.gov
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …
[PDF] researchgate.net

[PDF][PDF] Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

A Schweizer - Vascular Health and Risk Management, 2013 - researchgate.net
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin.

A Schweizer, JE Foley, W Kothny… - Vascular Health and Risk …, 2013 - europepmc.org
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

A Schweizer, JE Foley, W Kothny… - Vascular Health and Risk …, 2013 - go.gale.com
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …
[HTML] nih.gov

[HTML][HTML] Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

A Schweizer, JE Foley, W Kothny… - Vascular Health and Risk …, 2013 - ncbi.nlm.nih.gov
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

A Schweizer, JE Foley, W Kothny… - Vascular Health and Risk …, 2013 - dovepress.com
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

A Schweizer, JE Foley, W Kothny… - Vascular Health and …, 2013 - search.proquest.com
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin.

A Schweizer, JE Foley, W Kothny… - Vascular Health and Risk …, 2013 - europepmc.org
Due to the progressive nature of type 2 diabetes, many patients need insulin as add-on to
oral antidiabetic drugs (OADs) in order to maintain adequate glycemic control. Insulin …